You are here: All Products  > Takeda Approved to Launch Targeted Drug for NSCLC with Mutations in China

Takeda Approved to Launch Targeted Drug for NSCLC with Mutations in China

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products